Liftopram Plus 5 Tablet contains a combination of Clonazepam (0.5 mg) and Escitalopram Oxalate (5 mg), formulated to manage anxiety disorders and depression. Clonazepam, a benzodiazepine, exerts anxiolytic, anticonvulsant, and muscle relaxant effects by enhancing the activity of gamma-aminobutyric acid (GABA) in the central nervous system, thereby producing a calming effect. Escitalopram Oxalate, a selective serotonin reuptake inhibitor (SSRI), increases serotonin levels in the brain, which helps improve mood and reduce symptoms of depression and anxiety. The combination of these agents provides both immediate anxiolytic relief and long-term antidepressant benefits. Liftopram Plus 5 is indicated for the treatment of generalized anxiety disorder, panic disorder, and major depressive disorder, especially when symptoms require both rapid symptom control and sustained mood stabilization. Dosage should be individualized based on clinical response and tolerability, with caution advised in patients with a history of substance abuse, hepatic impairment, or concomitant use of other central nervous system depressants. Common side effects may include drowsiness, dizziness, dry mouth, and gastrointestinal disturbances. Patients should avoid alcohol and operating heavy machinery while on this medication. Use under strict medical supervision is recommended to monitor efficacy and adverse effects.